Drug recall · June 25, 2014
Vancomycin Hydrochloride Capsules recall
Why: Subpotent Drug.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Vancomycin Hydrochloride Capsules, USP, 250 mg. 20 Capsules on 2 x 10 Capsule Blister Cards, Rx Only. Mfd. for: Watson Pharma Inc., Parsippany, NJ 07054 USA. Mfd. by: Patheon Pharmaceuticals Inc., Cincinnati, OH 45237 USA. NDC 0591-3561-15.
- Lots / codes
Lot #: 3100135, Expiry: 05/2014
- Quantity
- 6913 packages
- Company
- Actavis Inc, Parsippany, NJ
- Distribution
- U.S. Nationwide
- Initiated
- May 16, 2014 · Voluntary: Firm initiated
- Classified
- June 17, 2014
- Reported
- June 25, 2014
- Ended
- February 23, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vancomycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.